SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is experiencing extreme volatility and heavy trading volume following a strategic partnership announcement with NVIDIA, which includes a multi-billion dollar cloud service agreement and equity-linked investment rights. While bullish investors view the move as long-term infrastructure validation and a transformation into an AI-compute powerhouse, the community is actively debating the impact of potential share dilution and the company's financial performance versus its ambitious growth narrative.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is currently trending as investors monitor its massive multi-year data center partnership with Cerebras Systems ahead of the upcoming Cerebras IPO. The community is actively debating the stock's valuation, weighing the impact of potential capital raises against the company's aggressive infrastructure expansion and its role as a key proxy play in the booming AI compute sector.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is experiencing intense market volatility and significant upward momentum as investors speculate on a long-term AI-driven memory supercycle, leading to a fierce debate between those betting on continued structural growth and those fearing a blow-off top. Community discussion is heavily focused on the stock's valuation relative to its forward earnings, the impact of sector-wide memory shortages, and comparisons to other high-momentum semiconductor plays.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing high volatility and significant trading interest fueled by optimism surrounding the CLARITY Act, which investors believe could provide a clear regulatory framework for stablecoin operations. The community remains focused on upcoming earnings and potential legislative updates, with many traders closely monitoring institutional positioning and the stock's ability to maintain upward momentum through key resistance levels.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is experiencing a surge driven by intense community focus on its niche role in the AI and semiconductor sectors, particularly its potential in edge computing and aerospace applications. Investors are actively debating the sustainability of its rapid price movement, comparing it to historical patterns in larger memory stocks while remaining divided over concerns regarding short-term volatility versus the company's long-term defense and industrial growth catalysts.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending due to a surge in retail interest following its recent earnings report and a non-binding MOU with AMD to develop enterprise AI infrastructure, prompting community debate over whether this represents a long-term turnaround or a potential rug pull. Traders are actively discussing the stock's significant debt load, the possibility of a share offering, and comparisons to previous momentum runners, with bullish sentiment focused on the potential for a gamma squeeze and institutional re-rating.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to a combination of positive clinical data updates and shifting market sentiment, including significant institutional volume. The community is actively discussing the stock's potential for a short squeeze alongside speculation regarding pipeline breakthroughs in oncology and new vaccine developments.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox Enterprises is facing high volatility as investors weigh solid earnings results and a multi-billion dollar pipeline against short-seller reports challenging its flagship AI power contracts. While the community is actively debating the legitimacy of these short-seller claims and the potential for a recovery, bulls are focused on the company's expanding project backlog and management's ongoing strategic growth in the data center energy sector.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidia Corporation is seeing significant investor interest as the community weighs strong Yutrepia launch momentum and high revenue growth against the ongoing patent litigation overhang with United Therapeutics. Traders are closely monitoring the court's calendar for a definitive ruling, which many believe serves as the primary catalyst for a potential breakout or valuation shift.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is trending as investors weigh strong operational results, including record quarterly cash flows and a dividend increase, against a volatile geopolitical backdrop and ongoing production challenges. The community is actively debating the company's valuation upside and the impact of the pending North American asset IPO, while monitoring gold's structural role in hedging against persistent economic uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$DCTH Delcath has trials in mBC and mCRC comparing Hepzato + SOC vs SOC. These trials are expensive to run for such  a small company. I wonder at what point will other companies approach Delcath and say &quot;we want to trial Hepzato in combination with our drug to treat a certain cancer that has liver mets&quot;. For example, Ideaya Biosciences has an mUM drug which is being trialled in the OPTIMUM trials. Ideaya may worry about getting squeezed out of the mUM space if the CHOPIN protocol of Hepzato + Immune Checkpoint Inhibitors (ICI), or Hepzato + Tebentafusp, become the new SOC for mUM.  Will CHOPIN exert pressure on other companies to try out their drug in combo with Hepzato? Might one of the immune checkpoint inhibitor companies try out (and pay for the trial) Hepzato+ICI in HCC - a huge market? Or perhaps one of the new immune therapy drug companies may try to hit a home run by trialling their new drug in combo with Hepzato in a particular liver dominated cancer? Or am I just dreaming?

Arden Wittman

Chip Davis

Sandi Harris

Thomas Prindle

StockTwits Web

Delcath Systems Inc

 Delcath has trials in mBC and mCRC comparing Hepzato + SOC vs SOC. These trials are expensive to run for such  a small company. I wonder at what point will other companies approach Delcath and say "we want to trial Hepzato in combination with our drug to treat a certain cancer that has liver mets". For example, Ideaya Biosciences has an mUM drug which is being trialled in the OPTIMUM trials. Ideaya may worry about getting squeezed out of the mUM space if the CHOPIN protocol of Hepzato + Immune Checkpoint Inhibitors (ICI), or Hepzato + Tebentafusp, become the new SOC for mUM.  Will CHOPIN exert pressure on other companies to try out their drug in combo with Hepzato? Might one of the immune checkpoint inhibitor companies try out (and pay for the trial) Hepzato+ICI in HCC - a huge market? Or perhaps one of the new immune therapy drug companies may try to hit a home run by trialling their new drug in combo with Hepzato in a particular liver dominated cancer? Or am I just dreaming?

Humdinger 1966

@Humdinger1966 dr zeyer has his trial with tebe+php.

Ideaya doesnt have a lot of money either. They won&#39;t do anymore trials until approval.

StockTwits For Android 

 dr zeyer has his trial with tebe+php.

Ideaya doesnt have a lot of money either. They won't do anymore trials until approval.

Alex Pitti

@alexpitti My point is not so much that IDYA will pay for a trial, but whether some company thinks to themselves, our drug might work really well with Hepzato lets do a trial, Why not? It would be sensational if Merck announced a trial of Keytruda+Hepzato. Do I think it will happen? I doubt it. But companies must be considering it, to get ahead of the opposition

 My point is not so much that IDYA will pay for a trial, but whether some company thinks to themselves, our drug might work really well with Hepzato lets do a trial, Why not? It would be sensational if Merck announced a trial of Keytruda+Hepzato. Do I think it will happen? I doubt it. But companies must be considering it, to get ahead of the opposition